IRON

Biotechnology IRON Uncategorized

Disc Medicine undergoes restructuring plan; slashes 20% of workforce

Feb 27, 2026

Biotechnology IRON Terry Chrisomalis Uncategorized

Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question

Feb 19, 2026

Biotechnology IRON Petri Dish Reports Uncategorized

Disc Medicine After The CRL: Risk Now Rests On APOLLO

Feb 17, 2026

Biotechnology IRON Uncategorized

Disc Medicine plunges on FDA Complete Response Letter for bitopertin

Feb 13, 2026

disc-medicine-and-sanofi-reportedly-face-delays-for-fda-national-priority-review-vouchers

ACHV Biotechnology GCVRZ IRON LLY RVMD SAN:CA SNY SNYNF Uncategorized

Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers

Jan 15, 2026

Comments Grandbrothers/iStock Editorial via Getty Images Two drugs developed by Disc Medicine (IRON) and Sanofi...